The potential clinical applications and prospects of microRNAs in lung cancer

被引：15

作者：

Gao, Ying ^{[1
]}

Gao, Fei ^{[2
]}

Ma, Jin-lu ^{[1
]}

Sun, Wen-ze ^{[1
]}

Song, Li-ping ^{[1
]}

机构：

[1] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Radiotherapy Oncol, Xian 710061, Peoples R China

[2] Xian Med Univ, Affiliated Hosp 1, Dept Neurol, Xian, Peoples R China

来源：

ONCOTARGETS AND THERAPY | 2014年 / 7卷

基金：

中国国家自然科学基金;

关键词：

microRNA; lung cancer; biomarker; chemotherapy; radiotherapy; TUMOR-SUPPRESSOR; EXPRESSION; CELLS; SENSITIVITY; RESISTANCE; GROWTH; RADIOSENSITIVITY; CHEMORESISTANCE; PROLIFERATION; PATHOGENESIS;

D O I：

10.2147/OTT.S62227

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Lung cancer is the major cause of cancer deaths worldwide due to its late diagnosis and poor outcome. Understanding genomic medicine may widen our vision into the oncogenesis of lung cancer and may open the door to improvements in the clinical management of lung cancer. It is well known that almost half of all genes are regulated by microRNAs (miRNAs). This review focuses on the role of miRNAs in lung cancer and also touches on the value of miRNA-based novel therapies for lung cancers.

引用

页码：901 / 905

页数：5

共 67 条

[1] Lost in translation: an assessment and perspective for computational microRNA target identification [J].

Alexiou, Panagiotis ;

Maragkakis, Manolis ;

Papadopoulos, Giorgos L. ;

Reczko, Martin ;

Hatzigeorgiou, Artemis G. .

BIOINFORMATICS, 2009, 25 (23) :3049-3055

[2] Coordinated Regulation of ATF2 by miR-26b in γ-Irradiated Lung Cancer Cells [J].

Arora, Himanshu ;

Qureshi, Rehana ;

Park, Ae-Kyung ;

Park, Woong-Yang .

PLOS ONE, 2011, 6 (08)

[3] miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFκB1 [J].

Arora, Himanshu ;

Qureshi, Rehana ;

Jin, Shunzi ;

Park, Ae-Kyoung ;

Park, Woong-Yang .

EXPERIMENTAL AND MOLECULAR MEDICINE, 2011, 43 (05) :298-304

[4] Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells [J].

Babar, Imran A. ;

Czochor, Jennifer ;

Steinmetz, Allison ;

Weidhaas, Joanne B. ;

Glazer, Peter M. ;

Slack, Frank J. .

CANCER BIOLOGY & THERAPY, 2011, 12 (10) :908-914

[5] The Promise of MicroRNA Replacement Therapy [J].

Bader, Andreas G. ;

Brown, David ;

Winkler, Matthew .

CANCER RESEARCH, 2010, 70 (18) :7027-7030

[6] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].

Bartel, David P. .

CELL, 2007, 131 (04) :11-29

[7] Artificial MicroRNAs as siRNA Shuttles: Improved Safety as Compared to shRNAs In vitro and In vivo [J].

Boudreau, Ryan L. ;

Martins, Ines ;

Davidson, Beverly L. .

MOLECULAR THERAPY, 2009, 17 (01) :169-175

[8] Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].

Calin, GA ;

Dumitru, CD ;

Shimizu, M ;

Bichi, R ;

Zupo, S ;

Noch, E ;

Aldler, H ;

Rattan, S ;

Keating, M ;

Rai, K ;

Rassenti, L ;

Kipps, T ;

Negrini, M ;

Bullrich, F ;

Croce, CM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529

[9] MicroRNA signatures in human cancers [J].

Calin, George A. ;

Croce, Carlo M. .

NATURE REVIEWS CANCER, 2006, 6 (11) :857-866

[10] miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease [J].

Castro, Rui E. ;

Ferreira, Duarte M. S. ;

Afonso, Marta B. ;

Borralho, Pedro M. ;

Machado, Mariana V. ;

Cortez-Pinto, Helena ;

Rodrigues, Cecilia M. P. .

JOURNAL OF HEPATOLOGY, 2013, 58 (01) :119-125

← 1 2 3 4 5 6 7 →